BillionToOne Revenue and Competitors
Estimated Revenue & Valuation
- BillionToOne's estimated annual revenue is currently $98.7M per year.
- BillionToOne's estimated revenue per employee is $195,903
- BillionToOne's total funding is $280M.
Employee Data
- BillionToOne has 504 Employees.
- BillionToOne grew their employee count by 28% last year.
BillionToOne's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder | Reveal Email/Phone |
2 | Co-founder and CEO | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | SVP Sales and Commercial Operations | Reveal Email/Phone |
5 | VP Quality and Regulatory | Reveal Email/Phone |
6 | VP, Revenue Cycle | Reveal Email/Phone |
7 | VP Business Development | Reveal Email/Phone |
8 | VP Medical Affairs, Prenatal | Reveal Email/Phone |
9 | VP, Reimbursement | Reveal Email/Phone |
10 | VP Business Development | Reveal Email/Phone |
BillionToOne Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is BillionToOne?
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending molecular counter platform is the only technology platform that can accurately count the DNA molecules to the single-count level.
keywords:N/A$280M
Total Funding
504
Number of Employees
$98.7M
Revenue (est)
28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BillionToOne News
D., BillionToOne is a molecular diagnostics company with a mission to make molecular diagnostics more accurate, efficient, and accessible for...
Molecular diagnostics firm BillionToOne has raised $125m through a Series C funding round to expand its commercial and clinical teams and...
BillionToOne, headquartered in Menlo Park, California, is a molecular diagnostics company with a mission to make molecular diagnostics more...
BillionToOne, Inc., a Menlo Park, Calif.-based molecular diagnostics company, closed a $55m Series B funding round. The round, announced in June 2021, was led by existing investor Hummingbird Ventures and incoming investor Four Rivers Group with participation from Neotribe Ventures, Norwest Ven ...
BillionToOne, Inc., a Menlo Park, Calif.-based precision diagnostics company that invented the patent-pending QCT™ molecular counter platform, closed its follow-on Series A+ funding round of $15m. The round was led by previous investors Hummingbird Ventures and NeoTribe Ventures with participat ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $90.1M | 506 | 50% | $150M |
#2 | $74.7M | 513 | 28% | N/A |
#3 | $91.2M | 513 | -5% | $506.6M |
#4 | $72.3M | 514 | 19% | $190.1M |
#5 | $35M | 517 | 13% | N/A |